Identification of cancer stem cell subpopulations of CD34+ PLC/PRF/5 that result in three types of human liver carcinomas

Stem Cells and Development

Volumn 24, Issue 8, 2015, Pages 1008-1021

  Park, Su Cheol ^a,b   Nguyen, Ngoc Tue ^a   Eun, Jong Ryeol ^a,c   Zhang, Yanling ^a,d   Jung, Yong Jin ^a,e   Tschudy Seney, Benjamin ^a   Trotsyuk, Artem ^a   Lam, Alexander ^a   Ramsamooj, Rajendra ^a   Zhang, Yanghong ^a   Theise, Neil D ^f   Zern, Mark A ^a   Duan, Yuyou ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b Korea Cancer Center Hospital   (South Korea)

^c Yeungnam University College of Medicine   (South Korea)

^d SOUTHERN MEDICAL UNIVERSITY   (China)

^e Seoul National University College of Medicine   (South Korea)

^f ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; ALPHA 1 ANTITRYPSIN; ALPHA FETOPROTEIN; CD133 ANTIGEN; CD34 ANTIGEN; CYTOKERATIN 19; CYTOKERATIN 7; EPITHELIAL CELL ADHESION MOLECULE; HERMES ANTIGEN; INTERCELLULAR ADHESION MOLECULE 1; MICROSOMAL AMINOPEPTIDASE; THY 1 ANTIGEN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGENICITY; ARTICLE; BILE DUCT CARCINOMA; CANCER STEM CELL; CARCINOGENESIS; CARCINOGENICITY; CELL FUNCTION; CELL HETEROGENEITY; CELL ISOLATION; CELL LINEAGE; CELL SUBPOPULATION; CONTROLLED STUDY; GENE EXPRESSION; HEPATOMA CELL; HUMAN; HUMAN CELL; IMMUNE DEFICIENCY; LIVER CELL CARCINOMA; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROGENY; PROTEIN EXPRESSION; TUMOR XENOGRAFT; ANIMAL; CARCINOMA; CELL CULTURE; CLASSIFICATION; GENETICS; HEPG2 CELL LINE; LIVER TUMOR; METABOLISM; PATHOLOGY; TRANSPLANTATION;

MUS;

ANIMALS; ANTIGENS, CD34; CARCINOGENESIS; CARCINOMA; CELLS, CULTURED; HEP G2 CELLS; HUMANS; LIVER NEOPLASMS; MICE; NEOPLASTIC STEM CELLS;

EID: 84926512908     PISSN: 15473287     EISSN: 15578534     Source Type: Journal    
DOI: 10.1089/scd.2014.0405     Document Type: Article

References (43)

1. Llovet JM, A Burroughs and J Bruix. (2003). Hepatocellular carcinoma. Lancet 362:1907-1917.
2. Yao Z and L Mishra. (2009). Cancer stem cells and hepatocellular carcinoma. Cancer Biol Ther 8:1691-1698.
3. Reya T, SJ Morrison, MF Clark and IL Weissman. (2001). Stem cell, cancer and cancer stem cells. Nature 414:105-111.
4. Thorgeirsson SS and JW Grisham. (2002). Molecular pathogenesis of human hepatocellular carcinoma. Nat Genet 31:339-346.
5. Lee JS, J Heo, L Libbrecht, IS Chu, P Kaposi-Novak, DF Calvisi, A Mikaelyan, LR Roberts, AJ Demetris, et al. (2006). A novel prognostic subtype of human hepatocellular carcinoma derived from hepatic progenitor cells. Nat Med 12:410-416.
6. Chiba T, Y Zheng, K Kita, O Yokosuka, H Saisho, M Onodera, H Miyoshi, M Nakano, Y Zen, et al. (2007). Enhanced self-renewal capability in hepatic stem/progenitor cells drives cancer initiation. Gastroenterology 133: 937-950.
7. Yang ZF, DW Ho, MN Ng, CK Lau, WC Yu, P Ngai, PWK Chu, CT Lam, RTP Poon, et al. (2008). Significance of CD90+ cancer stem cells in human liver cancer. Cancer Cell 13:153-166.
8. Ma S, K Chan, L Hu, TK Lee, JY Wo, IO Ng, B Zheng and Guan X. (2007). Identification and characterization of tumorigenic liver stem/progenitor cells. Gastroenterology 132:2542-2556.
9. Ding W, M Mouzaki, H You, JC Laird, J Mato, SC Lu and CB Rountree. (2009). CD133+ liver cancer stem cells from methionine adenosyl transferase 1A-deficient mice demonstrate resistance to transforming growth-factor (TGF)-beta-induced apoptosis. Hepatology 49:1277-1286.
10. Zhu Z, X Hao, M Yan, M Yao, C Ge, J Gu and J Li. (2009). Cancer stem/progenitor cells are highly enriched in CD133(+ ) CD44(+ ) population in hepatocellular carcinoma. Int J Cancer 126:2067-2078.
11. Yamashita T, J Ji, A Budhu, M Forgues, W Yang, H Wang, H Jia, Q Ye, L Qin, et al. (2009). EpCAM-positive hepatocellular carcinoma cells are tumor-initiating cells with stem/progenitor cell features. Gastroenterology 136:1012-1024.
12. Wu X and D Chen. (2006). Origin of hepatocellular carcinoma: role of stem cells. J Gastroenterol Hepatol 21: 1093-1098.
13. Eckersley-Maslin MA, FJ Warner, CA Grzelak, GW McCaughan and NA Shackel. (2009). Bone marrow stem cells and the liver: are they relevant? J Gastroenterol Hepatol 24:1608-1616.
14. Duncan AW, C Dorrell and M Grompe. (2009). Stem cells and liver regeneration. Gastroenterology 137:466-481.
15. Duan Y, X Ma, W Zou, C Wang, IS Bahbahan, TP Ahuja, V Tolstikov and MA Zern. (2010). Differentiation and characterization of metabolically functioning hepatocytes from human embryonic stem cells. Stem Cells 28:674-686.
16. Duan Y, A Catana, Y Meng, N Yamamoto, S He, S Gupta, SS Gambhir and MA Zern. (2007). Differentiation and enrichment of hepatocyte-like cells from human embryonic stem cells in vitro and in vivo. Stem Cells 25:3058-3068.
17. Van Mourik JA, OC Leeksma, JH Reinders, PG de Groot and J Zandbergen-Spaargaren. (1985). Vascular endothelia cells synthesize a plasma membrane protein indistinguishable from the platelet membrane glycoprotein lla. J Biol Chem 260:11300-11306.
18. Stockinger H, SJ Gadd, R Eher, O Majdic, W Schreiber, W Kasinrerk, B Strass, E Schnabl and W Knapp. (1990). Molecular characterization and functional analysis of the leukocyte surface protein CD31. J Immunol 145:3889-3897.
19. Alexander JJ, EM Bey, EW Geddes and G Lecatsas. (1976). Establishment of a continuously growing cell line from primary carcinoma of the liver. S Afr Med J 50:2124-2148.
20. Lau SK, S Prakash, SA Geller and Alsabeh R. (2002). Comparative immunohistochemical profile of hepatocellular carcinoma, cholangiocarcinoma, and metastatic adenocarcinoma. Hum Pathol 33:1175-1181.
21. Chu PG, RE Schwarz, SK Lau, Y Yen and LM Weiss. (2005). Immunohistochemical staining in the diagnosis of pancreatobiliary and ampulla of Vater adenocarcinoma: application of CDX2, CK17, MUC1, and MUC2. Am J Surg Pathol 29:359-367.
22. Rullier A, B Le Bail, R Fawaz, JF Blanc, J Saric and P Bioulac-Sage. (2000). Cytokeratin 7 and 20 expression in cholangiocarcinomas varies along the biliary tract but still differs from that in colorectal carcinoma metastasis. Am J Surg Pathol 24:870-876.
23. Yang W, C Wang, Y Lin, Q Liu, L Yu, L Tang, H Yan, J Fu, Y Chen, et al. (2012). OV6+ tumor-initiating cells contribute to tumor progression and invasion in human hepatocellular carcinoma. J Hepatol 57:613-620.
24. Sell S and HA Dunsford. (1989). Evidence for the stem cell origin of hepatocellular carcinoma and cholangiocarcinoma. Am J Pathol 134:1347-1363.
25. Sell S and HL Leffert. (1982). An evaluation of cellular lineage in the pathogenesis of experimental hepatocellular carcinoma. Hepatology 2:77-86.
26. Alison MR, M Golding, CE Sarraf, RJ Edwards and EN Lalani. (1996). Liver damage in the rat induces hepatocyte stem cells from biliary epithelial cells. Gastroentrology 110:1182-1190.
27. Dorrell C, L Erker, KM Lanxon-Cookson, SL Abraham, T Victoroff, S Ro, PS Canaday, PR Streeter and M Grompe. (2008). Surface markers for the murine oval cell response. Hepatology 48:1282-1291.
28. Wang X, M Foster, M Al-Dhalimy, E Lagasse, M Finegold and M Grompe. (2003). The origin and liver repopulating capacity of murine oval cells. Proc Natl Acad Sci U S A 100:11881-11888.
29. Theise ND, R Saxena, BC Portmann, SN Thung, H Yee, L Chiriboga, A Kumar and JM Crawford. (1999). The canals of Hering and hepatic stem cells in human. Hepatology 30:1425-1433.
30. Baumann U, HA Crosby, P Ramani, DA Kelly and AJ Strain. (1999). Expression of the stem cell factor receptor c-kit in normal and disease pediatric liver: identification of a human hepatic progenitor cell? Hepatology 30: 112-117.
31. Navarro-Alvarez N, A Soto-Gutierrez and N Kobayashi. (2010). Hepatic stem cells and liver development. Methods Mol Biol 640:181-236.
32. Arii S and M Imamura. (2007). Physiological role of sinusoidal endothelial cells and Kupffer cells and their implication in the pathogenesis of liver injury. J Hepatobiliary Pancreat Surg 7:40-48.
33. Petersen BE, WC Bowen, KD Patrene, WM Mars, AK Sullivan, N Murase, SS Boggs, JS Greenberger and JP Goff. (1999). Bone marrow as a potential source of hepatic oval cells. Science 284:1168-1170.
34. Theise ND, S Badve, R Saxena, O Henegariu, S Sell, JM Crawford and DS Krause. (2000). Derivation of hepatocytes from bone marrow cells in mice after radiationinduced myeloablation. Hepatology 31:235-240.
35. Lagasse E, H Connors, M Al-Dhalimy, M Reitsma, M Dohse, L Osborne, X Wang, M Finegold, IL Weissman, et al. (2000). Purified hematopoietic stem cells can differentiate into hepatocytes in vivo. Nat Med 6:1229-1234.
36. Jang Y, MI Collector, SB Baylin, AM Diehl and S Sharkis. (2004). Hematopoietic stem cells convert into liver cells within days without fusion. Nat Cell Biol 6:532-539.
37. Harris RG, EL Herzog, EM Bruscia, JE Grove, JS Van Arnam and DS Krause. (2004). Lack of a fusion requirement for development of bone marrow-derived epithelia. Science 305:90-93.
38. Schwartz RE, M Reyes, L Koodie, Y Jiang, M Blackstad, T Lund, T Lenvik, S Johnson, WS Hu, et al. (2002). Multipotent adult progenitor cells from bone marrow differentiate into functional hepatocyte-like cells. J Clin Invest 109:1291-1302.
39. Willenbring H, AS Bailey, M Foster, Y Akkari, C Dorrell, S Olson, M Finegold, WH Fleming and M Grompe. (2004). Myelomonocytic cells are sufficient for therapeutic cell fusion in the liver. Nat Med 10:744-748.
40. Wang X, H Willenbring, Y Akkari, Y Torimaru, M Foster, M Al-Dhalimy, E Lagasse, M Finegold, S Olson, et al. (2003). Cell fusion is the principal source of bone-marrowderived hepatocytes. Nature 422:897-901.
41. Alison MR, R Poulsom, R Jeffery, AP Dhillon, A Quaglia, J Jacob, M Novelli, G Prentice, J Williamson, et al. (2000). Hepatocytes from non-hepatic adult stem cells. Nature 406:257.
42. Theise ND, M Nimmakayalu, R Gardner, PB Illei, G Morgan, L Teperman, O Henegariu and DS Krause. (2000). Liver from bone marrow in humans. Hepatology 32:11-16.
43. Thorgeirsson SS and JW Grisham. (2006). Hematopoietic cells as hepatocyte stem cells: a critical review of the evidence. Hepatology 43:2-8.